Report Detail

Pharma & Healthcare COVID-19 Impact on Global Oral Contraceptive Drugs Market Insights, Forecast to 2026

  • RnM4017990
  • |
  • 09 June, 2020
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Oral Contraceptive Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Contraceptive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oral Contraceptive Drugs market is segmented into
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives

Segment by Application, the Oral Contraceptive Drugs market is segmented into
Hospital
Pharmacy
Other

Regional and Country-level Analysis
The Oral Contraceptive Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Contraceptive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Contraceptive Drugs Market Share Analysis
Oral Contraceptive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Contraceptive Drugs business, the date to enter into the Oral Contraceptive Drugs market, Oral Contraceptive Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong


1 Study Coverage

  • 1.1 Oral Contraceptive Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Oral Contraceptive Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Oral Contraceptive Drugs Market Size Growth Rate by Type
    • 1.4.2 Long-acting Contraceptives
    • 1.4.3 Short-acting Contraceptives
    • 1.4.4 Emergency Contraceptives
  • 1.5 Market by Application
    • 1.5.1 Global Oral Contraceptive Drugs Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Pharmacy
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Oral Contraceptive Drugs Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Oral Contraceptive Drugs Industry
      • 1.6.1.1 Oral Contraceptive Drugs Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Oral Contraceptive Drugs Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Oral Contraceptive Drugs Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Oral Contraceptive Drugs Market Size Estimates and Forecasts
    • 2.1.1 Global Oral Contraceptive Drugs Revenue 2015-2026
    • 2.1.2 Global Oral Contraceptive Drugs Sales 2015-2026
  • 2.2 Oral Contraceptive Drugs Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Oral Contraceptive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Oral Contraceptive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Oral Contraceptive Drugs Competitor Landscape by Players

  • 3.1 Oral Contraceptive Drugs Sales by Manufacturers
    • 3.1.1 Oral Contraceptive Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Oral Contraceptive Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Oral Contraceptive Drugs Revenue by Manufacturers
    • 3.2.1 Oral Contraceptive Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Oral Contraceptive Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Oral Contraceptive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Oral Contraceptive Drugs Revenue in 2019
    • 3.2.5 Global Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Oral Contraceptive Drugs Price by Manufacturers
  • 3.4 Oral Contraceptive Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Oral Contraceptive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Oral Contraceptive Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Oral Contraceptive Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Oral Contraceptive Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Oral Contraceptive Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Oral Contraceptive Drugs Revenue by Type (2015-2020)
    • 4.1.3 Oral Contraceptive Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Oral Contraceptive Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Oral Contraceptive Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Oral Contraceptive Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Oral Contraceptive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Oral Contraceptive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Oral Contraceptive Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Oral Contraceptive Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Oral Contraceptive Drugs Revenue by Application (2015-2020)
    • 5.1.3 Oral Contraceptive Drugs Price by Application (2015-2020)
  • 5.2 Oral Contraceptive Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Oral Contraceptive Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Oral Contraceptive Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Oral Contraceptive Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Oral Contraceptive Drugs by Country
    • 6.1.1 North America Oral Contraceptive Drugs Sales by Country
    • 6.1.2 North America Oral Contraceptive Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Oral Contraceptive Drugs Market Facts & Figures by Type
  • 6.3 North America Oral Contraceptive Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Oral Contraceptive Drugs by Country
    • 7.1.1 Europe Oral Contraceptive Drugs Sales by Country
    • 7.1.2 Europe Oral Contraceptive Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Oral Contraceptive Drugs Market Facts & Figures by Type
  • 7.3 Europe Oral Contraceptive Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Oral Contraceptive Drugs by Region
    • 8.1.1 Asia Pacific Oral Contraceptive Drugs Sales by Region
    • 8.1.2 Asia Pacific Oral Contraceptive Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Oral Contraceptive Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Oral Contraceptive Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Oral Contraceptive Drugs by Country
    • 9.1.1 Latin America Oral Contraceptive Drugs Sales by Country
    • 9.1.2 Latin America Oral Contraceptive Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Oral Contraceptive Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Oral Contraceptive Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Oral Contraceptive Drugs by Country
    • 10.1.1 Middle East and Africa Oral Contraceptive Drugs Sales by Country
    • 10.1.2 Middle East and Africa Oral Contraceptive Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Oral Contraceptive Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Oral Contraceptive Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Oral Contraceptive Drugs Products Offered
    • 11.1.5 Bayer Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description, Business Overview and Total Revenue
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Oral Contraceptive Drugs Products Offered
    • 11.2.5 Pfizer Recent Development
  • 11.3 Teva Pharmaceutical
    • 11.3.1 Teva Pharmaceutical Corporation Information
    • 11.3.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
    • 11.3.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Products Offered
    • 11.3.5 Teva Pharmaceutical Recent Development
  • 11.4 Merck
    • 11.4.1 Merck Corporation Information
    • 11.4.2 Merck Description, Business Overview and Total Revenue
    • 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck Oral Contraceptive Drugs Products Offered
    • 11.4.5 Merck Recent Development
  • 11.5 Actavis
    • 11.5.1 Actavis Corporation Information
    • 11.5.2 Actavis Description, Business Overview and Total Revenue
    • 11.5.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Actavis Oral Contraceptive Drugs Products Offered
    • 11.5.5 Actavis Recent Development
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Corporation Information
    • 11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
    • 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Johnson & Johnson Oral Contraceptive Drugs Products Offered
    • 11.6.5 Johnson & Johnson Recent Development
  • 11.7 Gedeon Richter
    • 11.7.1 Gedeon Richter Corporation Information
    • 11.7.2 Gedeon Richter Description, Business Overview and Total Revenue
    • 11.7.3 Gedeon Richter Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Gedeon Richter Oral Contraceptive Drugs Products Offered
    • 11.7.5 Gedeon Richter Recent Development
  • 11.8 Novo Nordisk A/S
    • 11.8.1 Novo Nordisk A/S Corporation Information
    • 11.8.2 Novo Nordisk A/S Description, Business Overview and Total Revenue
    • 11.8.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Products Offered
    • 11.8.5 Novo Nordisk A/S Recent Development
  • 11.9 ZiZhu
    • 11.9.1 ZiZhu Corporation Information
    • 11.9.2 ZiZhu Description, Business Overview and Total Revenue
    • 11.9.3 ZiZhu Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 ZiZhu Oral Contraceptive Drugs Products Offered
    • 11.9.5 ZiZhu Recent Development
  • 11.10 Baijingyu
    • 11.10.1 Baijingyu Corporation Information
    • 11.10.2 Baijingyu Description, Business Overview and Total Revenue
    • 11.10.3 Baijingyu Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Baijingyu Oral Contraceptive Drugs Products Offered
    • 11.10.5 Baijingyu Recent Development
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Oral Contraceptive Drugs Products Offered
    • 11.1.5 Bayer Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Oral Contraceptive Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Oral Contraceptive Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Oral Contraceptive Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Oral Contraceptive Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Oral Contraceptive Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Oral Contraceptive Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Oral Contraceptive Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Oral Contraceptive Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Oral Contraceptive Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Oral Contraceptive Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Oral Contraceptive Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Oral Contraceptive Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Oral Contraceptive Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Oral Contraceptive Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Oral Contraceptive Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Oral Contraceptive Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Oral Contraceptive Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Oral Contraceptive Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Oral Contraceptive Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Oral Contraceptive Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Oral Contraceptive Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Oral Contraceptive Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Oral Contraceptive Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Oral Contraceptive Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Oral Contraceptive Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Oral Contraceptive Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Oral Contraceptive Drugs is a syndicated market report, published as COVID-19 Impact on Global Oral Contraceptive Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Oral Contraceptive Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,112.20
    4,668.30
    6,224.40
    3,642.60
    5,463.90
    7,285.20
    609,453.00
    914,179.50
    1,218,906.00
    325,611.00
    488,416.50
    651,222.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report